Active Biotech AB

ACTI · Nasdaq Stockholm · Healthcare

3.79SEK −0.9%last day

Price as of 2 October 2026

The price over the past year, with dividends: −70.5%

Performance

1 month

−25.4%

1 year

−70.5%

3 years, per year

−46.6%

5 years, per year

−38.5%

Largest fall, 3 years

−90.4%

Below the peak now

−100.0%

Volatility, 1 year

107.9%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

2.6

Dividend yield

0.0%

Return on equity

−90.3%

Net margin

−183.9%

Market value

10 m USD

Quality, value and trend

Where Active Biotech stands against every Nordic stock today. 100 is best.

Quality73

Profitability and a sound balance sheet over time. Better than 73% of Nordic stocks.

Value5

The price measured against earnings, assets and cash flow. Better than 5% of Nordic stocks.

Trend4

The price development over the past year. Better than 4% of Nordic stocks.

Combined11

Quality, value and trend together. Better than 11% of Nordic stocks.

About Active Biotech

Active Biotech AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 5 employees.

Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase II clinical trial to treat hematological malignancies; Laquinimod, an immunomodulator for the treatment of severe inflammatory eye diseases, such as non-infectious non anterior uveitis; and Naptumomab estafenatox, a tumor targeting immunotherapy to treat patients with solid tumors.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis